TapewireFind a company

person · Reporting owner

FRIEDBERG ALBERT

Disclosed activity across 2 companies

Tapewire entity
78320
SEC CIK
0001268239

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Paramount Gold Nevada Corp.PZG · Entity 901610% ownerJune 13, 2025June 18, 2025
VACCINEX, INC.VCNX · Entity 9673Director · 10% ownerNovember 14, 2024November 18, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Paramount Gold Nevada Corp.

Report date June 13, 2025 · Filed June 18, 2025

Jointly reported with FCMI Parent Co., Buckingham Charitable Foundation

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivativeDirect9,692,310 Reported balance After 2025-06-13 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2025-06-13 · Purchase · Acquired 416,000 · Balance 9,692,310

F1: Of such 9,692,310 shares, 5,791,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by the Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg.

Filing footnotes · ownership attribution and instrument terms

F1: Of such 9,692,310 shares, 5,791,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by the Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg.

VACCINEX, INC.

Report date November 14, 2024 · Filed November 18, 2024

Jointly reported with FCMI Parent Co.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy FCMI Parent Co.1,051,389 Reported balance After 2024-11-14 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2024-11-14 · Grant · Acquired 30,756 · Balance 1,051,389

F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00IndirectBy FCMI Parent Co.584,646 Reported balance After 2024-11-14 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2024-11-14 · Grant · Acquired 584,646 · Balance 584,646

F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.

F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.64 · Expires 2029-09-18IndirectBy FCMI Parent Co.653,210 Reported balance Holding disclosure · report date 2024-11-14 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance 653,210

F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00IndirectBy FCMI Parent Co.102,960 Reported balance Holding disclosure · report date 2024-11-14 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 102,960

F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.

F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00IndirectBy FCMI Parent Co.92,504 Reported balance Holding disclosure · report date 2024-11-14 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 92,504

F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.

F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Common StockSEC Table I · non-derivativeDirect2,094 Reported balance Holding disclosure · report date 2024-11-14 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,094

Common StockSEC Table I · non-derivativeIndirectBy Pan Atlantic Holdings Ltd.180 Reported balance Holding disclosure · report date 2024-11-14 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 180

F1: Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectBy Friedberg Global-Macro Hedge Fund Ltd.16,724 Reported balance Holding disclosure · report date 2024-11-14 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 16,724

F2: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F2: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 13, 2025 Filed Jun 18, 2025 16:30 UTC Paramount Gold Nevada Corp. PZG · Entity 9016 PurchaseCommon Stock, par value $0.01 per share 416,000 $0.60 $249,600.00
Disclosure

SEC source: 0001213900-25-055670 · ownership.xml · nonDerivative · entry 1

FCMI Parent Co. · CIK 0001678258 · 10% owner

Buckingham Charitable Foundation · CIK 0001977540 · 10% owner

FRIEDBERG ALBERT · CIK 0001268239 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,692,310

F1 · ownership.direct: Of such 9,692,310 shares, 5,791,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by the Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 16:06 UTC VACCINEX, INC. VCNX · Entity 9673 GrantWarrant (Right to Buy) · Derivative 584,646 $3.25 Strike: $0.00 $1,900,041.04
Disclosure

SEC source: 0001062993-24-019266 · form4.xml · derivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 584,646

Underlying: Common Stock · 584,646 shares

Expires not disclosed

F4 · derivative.exercise_date: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.

F4 · derivative.expiration_date: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 16:06 UTC VACCINEX, INC. VCNX · Entity 9673 GrantCommon Stock 30,756 $3.25 $99,957.00
Disclosure

SEC source: 0001062993-24-019266 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 1,051,389

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 16:11 UTC VACCINEX, INC. VCNX · Entity 9673 GrantWarrant (Right to Buy) · Derivative 653,210 $0.13 Strike: $5.64 $81,651.25
Disclosure

SEC source: 0001062993-24-016838 · form4.xml · derivative · entry 8

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 653,210

Underlying: Common Stock · 653,210 shares

Expires 2029-09-18

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 16:11 UTC VACCINEX, INC. VCNX · Entity 9673 Exercise / conversionWarrant (Right to Buy) · Derivative 25,723 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-24-016838 · form4.xml · derivative · entry 7

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 92,504

Underlying: Common Stock · 25,723 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. FCMI partially exercised this warrant for 25,723 shares at an exercise price of $5.636 per share and pre-funded the remaining 92,504 shares at a price of $5.635. The exercise price for the remaining 92,504 shares underlying this warrant was subsequently adjusted to $0.001.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 16:11 UTC VACCINEX, INC. VCNX · Entity 9673 Exercise / conversionWarrant (Right to Buy) · Derivative 214,286 $0.00 Strike: $5.64 $0.00
Disclosure

SEC source: 0001062993-24-016838 · form4.xml · derivative · entry 6

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 0

Underlying: Common Stock · 214,286 shares

Expires 2028-10-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to a warrant inducement agreement by and between the issuer and FCMI dated September 17, 2024 (the "Warrant Inducement Agreement"), the exercise price of this warrant was adjusted to $5.636.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 16:11 UTC VACCINEX, INC. VCNX · Entity 9673 Exercise / conversionCommon Stock 25,723 $5.64 $144,974.83
Disclosure

SEC source: 0001062993-24-016838 · form4.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 1,020,633

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. FCMI partially exercised this warrant for 25,723 shares at an exercise price of $5.636 per share and pre-funded the remaining 92,504 shares at a price of $5.635. The exercise price for the remaining 92,504 shares underlying this warrant was subsequently adjusted to $0.001.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 16:11 UTC VACCINEX, INC. VCNX · Entity 9673 Exercise / conversionCommon Stock 214,286 $5.64 $1,207,715.90
Disclosure

SEC source: 0001062993-24-016838 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 994,910

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to a warrant inducement agreement by and between the issuer and FCMI dated September 17, 2024 (the "Warrant Inducement Agreement"), the exercise price of this warrant was adjusted to $5.636.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 16:30 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 100 $4.51 $451.00
Disclosure

SEC source: 0001062993-24-014976 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 780,624

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 16:04 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 2,753 $4.92 $13,544.76
Disclosure

SEC source: 0001062993-24-014577 · form4.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 780,524

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
August 05, 2024 Filed Aug 7, 2024 16:04 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 3,653 $4.60 $16,803.80
Disclosure

SEC source: 0001062993-24-014577 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 777,771

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 16:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 11,703 $4.72 $55,238.16
Disclosure

SEC source: 0001062993-24-014364 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 774,118

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 31, 2024 Filed Aug 1, 2024 16:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 16,128 $7.40 $119,282.69
Disclosure

SEC source: 0001062993-24-014289 · form4.xml · nonDerivative · entry 6

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 762,415

F6 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 31, 2024 Filed Aug 1, 2024 16:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 83,243 $6.41 $533,587.63
Disclosure

SEC source: 0001062993-24-014289 · form4.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 746,287

F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 31, 2024 Filed Aug 1, 2024 16:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 100,629 $5.74 $577,409.20
Disclosure

SEC source: 0001062993-24-014289 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 663,044

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
May 30, 2024 Filed May 31, 2024 16:31 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 861 $5.20 $4,472.90
Disclosure

SEC source: 0001062993-24-011556 · form4.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 562,415

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.20. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
May 29, 2024 Filed May 31, 2024 16:31 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 957 $4.95 $4,737.15
Disclosure

SEC source: 0001062993-24-011556 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 561,554

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
April 19, 2024 Filed Apr 22, 2024 16:33 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 282 $4.73 $1,333.86
Disclosure

SEC source: 0001062993-24-008643 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 560,597

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 20:53 UTC VACCINEX, INC. VCNX · Entity 9673 GrantWarrant (Right to Buy) · Derivative 102,960 $7.77 Strike: $7.64 $799,999.20
Disclosure

SEC source: 0001062993-24-007660 · form4.xml · derivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 102,960

Underlying: Common Stock · 102,960 shares

Expires 2029-03-28

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 20:53 UTC VACCINEX, INC. VCNX · Entity 9673 GrantCommon Stock 102,960 $7.77 $799,999.20
Disclosure

SEC source: 0001062993-24-007660 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 560,315

F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
February 08, 2024 Filed Feb 9, 2024 16:32 UTC VACCINEX, INC. VCNX · Entity 9673 GrantWarrant (Right to Buy) · Derivative 1,655,172 $0.73 Strike: $1.00 $1,199,999.70
Disclosure

SEC source: 0001062993-24-002769 · form4.xml · derivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 1,655,172

Underlying: Common Stock · 1,655,172 shares

Expires 2029-02-08

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
February 08, 2024 Filed Feb 9, 2024 16:32 UTC VACCINEX, INC. VCNX · Entity 9673 GrantCommon Stock 1,655,172 $0.73 $1,199,999.70
Disclosure

SEC source: 0001062993-24-002769 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 6,402,966

F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 16:30 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseWarrant (Right to Buy) · Derivative 3,000,000 $1.00 Strike: $1.00 $3,000,000.00
Disclosure

SEC source: 0001062993-23-019061 · form4.xml · derivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2028-10-03

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 16:30 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 3,000,000 $1.00 $3,000,000.00
Disclosure

SEC source: 0001062993-23-019061 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,747,794

F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
May 15, 2023 Filed May 16, 2023 16:33 UTC VACCINEX, INC. VCNX · Entity 9673 GrantCommon Stock 6,711,552 $0.37 $2,512,133.91
Disclosure

SEC source: 0001062993-23-011230 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 26,216,904

F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
May 10, 2023 Filed May 12, 2023 13:23 UTC Paramount Gold Nevada Corp. PZG · Entity 9016 PurchaseCommon Stock, par value $0.01 per share 4,300,000 $0.32 $1,376,000.00
Disclosure

SEC source: 0001019056-23-000244 · paramount.xml · nonDerivative · entry 1

FCMI Parent Co. · CIK 0001678258 · 10% owner

Buckingham Charitable Foundation · CIK 0001977540 · 10% owner

FRIEDBERG ALBERT · CIK 0001268239 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,276,310

F1 · ownership.direct: Of such 9,276,310 shares, 5,375,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by The Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg.

Read SEC document
March 31, 2023 Filed Apr 3, 2023 16:34 UTC VACCINEX, INC. VCNX · Entity 9673 GrantCommon Stock 4,146,341 $0.41 $1,699,999.81
Disclosure

SEC source: 0001062993-23-008323 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 19,505,352

F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
November 23, 2022 Filed Nov 28, 2022 16:35 UTC VACCINEX, INC. VCNX · Entity 9673 GrantCommon Stock 3,778,575 $0.53 $1,999,999.75
Disclosure

SEC source: 0001062993-22-022816 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 15,359,011

F4 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F4 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 16:24 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 1,801,801 $1.11 $1,999,999.11
Disclosure

SEC source: 0001062993-22-001867 · form4.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 11,580,436

F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F4 · balance_after: Includes 967,983 shares previously reported as being held indirectly through FCMI Financial Corporation.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 16:24 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 1,801,801 $1.11 $1,999,999.11
Disclosure

SEC source: 0001062993-22-001867 · form4.xml · nonDerivative · entry 3

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Friedberg Global-Macro Hedge Fund Ltd.

Disclosed balance after: 3,511,894

F2 · shares: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F2 · balance_after: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F2 · ownership.nature: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
May 24, 2021 Filed Jun 24, 2021 16:41 UTC VACCINEX, INC. VCNX · Entity 9673 ConversionOption (Right to Acquire) · Derivative 9,679,833 Not disclosed Not disclosed
Disclosure

SEC source: 0000891839-21-000232 · edgar.xml · derivative · entry 7

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Financial Corporation

Disclosed balance after: 0

Underlying: Common Stock · 967,983 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis.

F6 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis.

F6 · derivative.exercise_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis.

F6 · derivative.expiration_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis.

F4 · ownership.nature: FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.

Read SEC document
May 24, 2021 Filed Jun 24, 2021 16:41 UTC VACCINEX, INC. VCNX · Entity 9673 ConversionOption (Right to Acquire) · Derivative 21,475,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000891839-21-000232 · edgar.xml · derivative · entry 6

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 0

Underlying: Common Stock · 1,180,051 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis.

F5 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis.

F5 · derivative.exercise_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis.

F5 · derivative.expiration_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
May 24, 2021 Filed Jun 24, 2021 16:41 UTC VACCINEX, INC. VCNX · Entity 9673 ConversionCommon Stock 967,983 Not disclosed Not disclosed
Disclosure

SEC source: 0000891839-21-000232 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Financial Corporation

Disclosed balance after: 967,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis.

F4 · ownership.nature: FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.

Read SEC document
May 24, 2021 Filed Jun 24, 2021 16:41 UTC VACCINEX, INC. VCNX · Entity 9673 ConversionCommon Stock 1,180,051 Not disclosed Not disclosed
Disclosure

SEC source: 0000891839-21-000232 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 8,810,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis.

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 10, 2020 Filed Jul 10, 2020 16:18 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 1,126,760 $3.55 $3,999,998.00
Disclosure

SEC source: 0000891839-20-000208 · edgar.xml · nonDerivative · entry 3

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Friedberg Global-Macro Hedge Fund Ltd.

Disclosed balance after: 1,710,093

F2 · ownership.nature: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 10, 2020 Filed Jul 14, 2020 16:15 UTC Paramount Gold Nevada Corp. PZG · Entity 9016 OtherWarrants to purchase Common Stock · Derivative 380,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001019056-20-000414 · paramount.xml · derivative · entry 2

FCMI Parent Co. · CIK 0001678258 · 10% owner

FCMI FINANCIAL CORP ET AL · CIK 0000931301 · 10% owner

FRIEDBERG ALBERT · CIK 0001268239 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 190,000 shares

Expires 2020-07-10

F2 · kind: On July 10, 2020, the Warrants described in Table II expired in accordance with their terms. No consideration was paid to FCMI Parent Co. upon expiration of the Warrants.

F2 · price: On July 10, 2020, the Warrants described in Table II expired in accordance with their terms. No consideration was paid to FCMI Parent Co. upon expiration of the Warrants.

F1 · ownership.direct: Of such 4,976,310 shares, 3,754,099 shares are owned directly by FCMI Parent Co., and 1,222,211 shares are owned directly by FCMI Financial Corporation. FCMI Financial Corporation is a wholly-owned subsidiary of FCMI Parent Co. All of the Warrants reported as expired in Table II were owned directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg.

F2 · ownership.direct: On July 10, 2020, the Warrants described in Table II expired in accordance with their terms. No consideration was paid to FCMI Parent Co. upon expiration of the Warrants.

Read SEC document
March 30, 2020 Filed Mar 30, 2020 17:20 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 5,000 $4.06 $20,300.00
Disclosure

SEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,630,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 27, 2020 Filed Mar 30, 2020 17:20 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 4,000 $4.18 $16,720.00
Disclosure

SEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,625,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 26, 2020 Filed Mar 26, 2020 18:08 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 1,000 $4.44 $4,440.00
Disclosure

SEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,621,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 24, 2020 Filed Mar 26, 2020 18:08 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 2,000 $4.40 $8,800.00
Disclosure

SEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,620,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 20, 2020 Filed Mar 23, 2020 17:24 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 2,000 $4.31 $8,620.00
Disclosure

SEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,618,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 17:24 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 4,000 $4.15 $16,600.00
Disclosure

SEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,616,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 17, 2020 Filed Mar 17, 2020 20:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 3,440 $4.00 $13,760.00
Disclosure

SEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 6

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,612,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 16, 2020 Filed Mar 17, 2020 20:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 600 $4.15 $2,490.00
Disclosure

SEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,609,161

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 13, 2020 Filed Mar 17, 2020 20:05 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 3,000 $4.28 $12,840.00
Disclosure

SEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,608,561

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 10, 2020 Filed Mar 11, 2020 17:09 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 4,000 $4.20 $16,800.00
Disclosure

SEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,605,561

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 17:09 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 231 $4.22 $974.82
Disclosure

SEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,601,561

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
January 23, 2020 Filed Jan 27, 2020 16:25 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 982,318 $5.09 $4,999,998.62
Disclosure

SEC source: 0000891839-20-000034 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,601,330

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 30, 2019 Filed Jul 31, 2019 16:30 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 1,838,235 $4.08 $7,499,998.80
Disclosure

SEC source: 0000891839-19-000142 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 6,619,012

F3 · balance_after: This Form 4 corrects a prior inadvertent administrative error as to the total beneficial ownership reported.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 26, 2019 Filed Jul 29, 2019 16:37 UTC VACCINEX, INC. VCNX · Entity 9673 PurchaseCommon Stock 1,000 $3.99 $3,990.00
Disclosure

SEC source: 0000891839-19-000134 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,791,521

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.